These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29324370)

  • 1. Model-based comparing efficacy of fluoxetine between elderly and non-elderly participants with major depressive disorder.
    Dong L; Xu L; Li Y; Lv Y; Liu H; Li Y; Xu F; Wu J; Zheng Q; Li L
    J Affect Disord; 2018 Mar; 229():224-230. PubMed ID: 29324370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
    Lam RW; Levitt AJ; Levitan RD; Michalak EE; Cheung AH; Morehouse R; Ramasubbu R; Yatham LN; Tam EM
    JAMA Psychiatry; 2016 Jan; 73(1):56-63. PubMed ID: 26580307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex- and age-related differences in major depressive disorder with comorbid anxiety treated with fluoxetine.
    Cassano P; Soares CN; Cohen LS; Lyster AK; Fava M
    Arch Womens Ment Health; 2004 Jul; 7(3):167-71. PubMed ID: 15241662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.
    Eckert L; Lançon C
    BMC Psychiatry; 2006 Jul; 6():30. PubMed ID: 16867188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder.
    Papakostas GI; Petersen T; Homberger CH; Green CH; Smith J; Alpert JE; Fava M
    Ann Clin Psychiatry; 2007; 19(1):5-8. PubMed ID: 17453655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
    Cornelius JR; Bukstein OG; Douaihy AB; Clark DB; Chung TA; Daley DC; Wood DS; Brown SJ
    Drug Alcohol Depend; 2010 Nov; 112(1-2):39-45. PubMed ID: 20576364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain has a strong negative impact on the fluoxetine response in hospitalized patients with major depressive disorder.
    Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
    Clin J Pain; 2011; 27(9):805-10. PubMed ID: 21677571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between symptom relief and functional improvement during acute fluoxetine treatment for patients with major depressive disorder.
    Lin CH; Chou LS; Chen MC; Chen CC
    J Affect Disord; 2015 Aug; 182():115-20. PubMed ID: 25985380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial.
    Salardini E; Zeinoddini A; Mohammadinejad P; Khodaie-Ardakani MR; Zahraei N; Zeinoddini A; Akhondzadeh S
    J Psychiatr Res; 2016 Apr; 75():24-30. PubMed ID: 26800392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U; Onder E
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of medical comorbidity on acute treatment in major depressive disorder.
    Iosifescu DV; Nierenberg AA; Alpert JE; Smith M; Bitran S; Dording C; Fava M
    Am J Psychiatry; 2003 Dec; 160(12):2122-7. PubMed ID: 14638581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of fluoxetine remission for hospitalized patients with major depressive disorder.
    Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):510-7. PubMed ID: 21851460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melancholic features in inpatients with major depressive disorder associate with differential clinical characteristics and treatment outcomes.
    Lin CH; Huang CJ; Liu SK
    Psychiatry Res; 2016 Apr; 238():368-373. PubMed ID: 26899817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both body weight and BMI predicts improvement in symptom and functioning for patients with major depressive disorder.
    Lin CH; Chen CC; Wong J; McIntyre RS
    J Affect Disord; 2014 Jun; 161():123-6. PubMed ID: 24751319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.